Cathy N Lam

Array ( [id] => 6026544 [patent_doc_number] => 20110054020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'NAPTHYLENE INHIBITORS OF CYCLOOXYGENASE' [patent_app_type] => utility [patent_app_number] => 12/773329 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13899 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054020.pdf [firstpage_image] =>[orig_patent_app_number] => 12773329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987040 [patent_doc_number] => 20110098291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'ANTAGONIST OF SMOOTHENED' [patent_app_type] => utility [patent_app_number] => 12/773656 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10257 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098291.pdf [firstpage_image] =>[orig_patent_app_number] => 12773656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388813 [patent_doc_number] => 20100317706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'HNF4alpha MODULATORS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/771780 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 40447 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317706.pdf [firstpage_image] =>[orig_patent_app_number] => 12771780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199412 [patent_doc_number] => 20120122875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Salts of Methyl (R)-7-[3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyryl]-3-Trifluoromethyl-5,6,7,8-Tetrahydro-Imidazo[1,5-A]Pyrazine-1-Carboxylate' [patent_app_type] => utility [patent_app_number] => 13/322142 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4022 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122875.pdf [firstpage_image] =>[orig_patent_app_number] => 13322142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007931 [patent_doc_number] => 20110059962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/765528 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26835 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059962.pdf [firstpage_image] =>[orig_patent_app_number] => 12765528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768227 [patent_doc_number] => 20120035270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER' [patent_app_type] => utility [patent_app_number] => 13/265739 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6858 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035270.pdf [firstpage_image] =>[orig_patent_app_number] => 13265739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018459 [patent_doc_number] => 09060928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Tacrolimus injection preparation' [patent_app_type] => utility [patent_app_number] => 13/255127 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3867 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074614 [patent_doc_number] => 08552193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide' [patent_app_type] => utility [patent_app_number] => 12/750777 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6972 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074614 [patent_doc_number] => 08552193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide' [patent_app_type] => utility [patent_app_number] => 12/750777 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6972 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12750777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638190 [patent_doc_number] => 20100173927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'BELOXEPIN AND ANALOGS FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/750558 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12279 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173927.pdf [firstpage_image] =>[orig_patent_app_number] => 12750558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6229078 [patent_doc_number] => 20100183774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'GLUCOSAMINE AS A FOOD AND BEVERAGE ADDITIVE' [patent_app_type] => utility [patent_app_number] => 12/748650 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7886 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183774.pdf [firstpage_image] =>[orig_patent_app_number] => 12748650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626788 [patent_doc_number] => 08796466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 12/729940 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80104 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12729940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140823 [patent_doc_number] => 20120094967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASES' [patent_app_type] => utility [patent_app_number] => 13/256560 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10311 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094967.pdf [firstpage_image] =>[orig_patent_app_number] => 13256560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731458 [patent_doc_number] => 20120014918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'ADDITION SALTS OF AMINES CONTAINING HYDROXYL AND/OR CARBOXYLIC GROUPS WITH AMINO NICOTINIC ACID DERIVATIVES AS DHODH INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/256349 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10941 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014918.pdf [firstpage_image] =>[orig_patent_app_number] => 13256349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720876 [patent_doc_number] => 20120010211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 13/257945 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6682 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010211.pdf [firstpage_image] =>[orig_patent_app_number] => 13257945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670110 [patent_doc_number] => 20110319379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'Substituted Indazole Amides And Their Use As Glucokinase Activators' [patent_app_type] => utility [patent_app_number] => 13/255329 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38417 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815178 [patent_doc_number] => 20130116223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'MEDICINAL COSMETIC LIPOATROPHY' [patent_app_type] => utility [patent_app_number] => 13/810022 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5500 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6419946 [patent_doc_number] => 20100150898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'COMPOUNDS AND METHODS FOR THE TREATMENT OF AIRWAY DISEASES AND FOR THE DELIVERY OF AIRWAY DRUGS' [patent_app_type] => utility [patent_app_number] => 12/709960 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4900 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150898.pdf [firstpage_image] =>[orig_patent_app_number] => 12709960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8082517 [patent_doc_number] => 08148576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Solid state forms of aliskiren compounds' [patent_app_type] => utility [patent_app_number] => 12/701295 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 9568 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148576.pdf [firstpage_image] =>[orig_patent_app_number] => 12701295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104289 [patent_doc_number] => 08153796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 12/696149 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21157 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153796.pdf [firstpage_image] =>[orig_patent_app_number] => 12696149 [rel_patent_id] =>[rel_patent_doc_number] =>)